Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

This article focuses on the common regulatory threads that connect different regions and the global standards and principles ...

AI and machine learning can transform fragmented and unstructured healthcare data. But how do you refine it into useful, ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...